P38α is required for ovarian cancer cell metabolism and survival

International Journal of Gynecological Cancer

Volumn 20, Issue 2, 2010, Pages 203-211

  Matrone, Antonio ^a   Grossi, Valentina ^a   Chiacchiera, Fulvio ^a   Fina, Emanuela ^a   Cappellari, Marianna ^a   Caringella, Anna Maria ^b   Di Naro, Edoardo ^b   Loverro, Giuseppe ^b   Simone, Cristiano ^a  

^a Laboratory of Signal dependent Transcription   (Italy)

^b UNIVERSITY OF BARI   (Italy)

Author keywords

AMPK; Autophagy; FoxO3A; Hif1 ; Ovarian cancer; P38

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 HYDROXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ADENOSINE PHOSPHATE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; ISOENZYME; MITOGEN ACTIVATED PROTEIN KINASE 14; PROTEIN KINASE; TRANSCRIPTION FACTOR FKHRL1; FORKHEAD TRANSCRIPTION FACTOR; FOXO3 PROTEIN, HUMAN; HIF1A PROTEIN, HUMAN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE;

ARTICLE; AUTOPHAGY; CANCER CELL CULTURE; CANCER GROWTH; CELL METABOLISM; CELL PROLIFERATION; CELL STRAIN HT29; CELL STRUCTURE; CELL SURVIVAL; CELL VACUOLE; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; GENETIC TRANSCRIPTION; GROWTH INHIBITION; HOMEOSTASIS; HUMAN; HUMAN CELL; MODULATION; MOLECULAR MECHANICS; OVARY CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; CARCINOMA; GENE EXPRESSION REGULATION; METABOLISM; OVARY TUMOR; TUMOR CELL LINE;

AMP-ACTIVATED PROTEIN KINASES; CARCINOMA; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION, NEOPLASTIC; HOMEOSTASIS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MITOGEN-ACTIVATED PROTEIN KINASE 14; OVARIAN NEOPLASMS; SIGNAL TRANSDUCTION;

EID: 77951887477     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1111/IGC.0b013e3181c8ca12     Document Type: Article

References (26)

1. Denko NC. Hypoxia, HIF1 and glucose metabolism in the solid tumour. Nat Rev Cancer. 2008;8:705-713.
2. Gambhir SS. Molecular imaging of cancer with positron emission tomography. Nat Rev Cancer. 2002;2:683-693.
3. Mankoff DA, Eary JF, Link JM, et al. Tumor-specific positron emission tomography imaging in patients: [18F] fluorodeoxyglucose and beyond. Clin Cancer Res. 2007;13:3460-3469.
4. Gatenby RA, Gillies RJ. Why do cancers have high aerobic glycolysis? Nat Rev Cancer. 2004;4:891-899.
5. Kroemer G, Pouyssegur J. Tumor cell metabolism: cancer's Achilles' heel. Cancer Cell. 2008;13:472-482.
6. Hsu PP, Sabatini DM. Cancer cell metabolism: Warburg and beyond. Cell. 2008;134:703-707.
7. Minet E, Michel G, Mottet D, et al. Transduction pathways involved in Hypoxia-Inducible Factor-1 phosphorylation and activation. Free Radic Biol Med. 2001;31:847-855.
8. Emerling BM, Platanias LC, Black E, et al. Mitochondrial reactive oxygen species activation of p38 mitogen-activated protein kinase is required for hypoxia signaling. Mol Cell Biol. 2005;25:4853-4862.
9. Kwon SJ, Song JJ, Lee YJ. Signal pathway of hypoxia-inducible factor-1alpha phosphorylation and its interaction with von Hippel-Lindau tumor suppressor protein during ischemia in MiaPaCa-2 pancreatic cancer cells. Clin Cancer Res. 2005;11:7607-7613.
10. Chiacchiera F, Simone C. Signal-dependent regulation of gene expression as a target for cancer treatment: inhibiting p38alpha in colorectal tumors. Cancer Lett. 2008;265:16-26.
11. Wagner EF, Nebreda AR. Signal integration by JNK and p38 MAPK pathways in cancer development. Nat Rev Cancer. 2009;9:537-549.
12. Comes F, Matrone A, Lastella P, et al. A novel cell type-specific role of p38alpha in the control of autophagy and cell death in colorectal cancer cells. Cell Death Differ. 2007;14:693-702.
13. Chiacchiera F, Matrone A, Ferrari E, et al. p38alpha blockade inhibits colorectal cancer growth in vivo by inducing a switch from HIF1alpha-to FoxO-dependent transcription. Cell Death Differ. 2009;16:1203-1214.
14. Chiacchiera F, Simone C. Inhibition of p38alpha unveils an AMPK-FoxO3A axis linking autophagy to cancer-specific metabolism. Autophagy. 2009;5:1030-1033.
15. Galanis A, Pappa A, Giannakakis A, et al. Reactive oxygen species and HIF-1 signalling in cancer. Cancer Lett. 2008;266:12-20.
16. Favaro E, Nardo G, Persano L, et al. Hypoxia inducible factor-1alpha inactivation unveils a link between tumor cell metabolism and hypoxia-induced cell death. Am J Pathol. 2008;173:1186-1201.
17. Shimogai R, Kigawa J, Itamochi H, et al. Expression of hypoxiainducible factor 1alpha gene affects the outcome in patients with ovarian cancer. Int J Gynecol Cancer. 2008;18:499-505.
18. Calnan DR, Brunet A. The FoxO code. Oncogene. 2008;27:2276-2288.
19. Fernández de Mattos S, Essafi A, Soeiro I, et al. FoxO3a and BCR-ABL regulate cyclin D2 transcription through a STAT5/BCL6-dependent mechanism. Mol Cell Biol. 2004;24:10058-10071.
20. Ho KK, Myatt SS, Lam EW. Many forks in the path: cycling with FoxO. Oncogene. 2008;27:2300-2311.
21. Simone C. Signal-dependent control of autophagy and cell death in colorectal cancer cell: the role of the p38 pathway. Autophagy. 2007;3:468-471. (Pubitemid 47293729)
22. Bukowski RM, Ozols RF, Markman M. The management of recurrent ovarian cancer. Semin Oncol. 2007;34: S1YS15.
23. Igney FH, Krammer PH. Death and anti-death: tumour resistance to apoptosis. Nat Rev Cancer. 2002;2:277-288.
24. Herr I, Debatin KM. Cellular stress response and apoptosis in cancer therapy. Blood. 2001;98:2603-2614.
25. Fernández de Mattos S, Villalonga P, Clardy J, et al. FOXO3a mediates the cytotoxic effects of cisplatin in colon cancer cells. Mol Cancer Ther. 2008;7:3237-3246.
26. Steelman LS, Stadelman KM, Chappell WH, et al. Akt as a therapeutic target in cancer. Expert Opin Ther Targets. 2008;12:1139-1165.